Thermo Fisher Scientific to Sell its Cell Culture, Gene Modulation and Magnetic Beads Businesses to GE Healthcare for $1.06B

by Charles Gross, Benzinga Editor
January 6, 2014 7:01 AM | 20 seconds read | Make a Comment
Loading...
Loading...
Thermo Fisher Scientific
TMO
today announced that it has signed an agreement to sell its cell culture (sera and media), gene modulation and magnetic beads businesses to GE Healthcare, a unit of General Electric Company
GE
, for approximately $1.06 billion. The businesses will become part of GE Healthcare's Life Sciences division.
See full press release
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Posted In: NewsGuidanceAsset SalesManagementM&AGlobal
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!